These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22850927)

  • 1. Synthesis and preliminary biological evaluation of carba analogues from Neisseria meningitidis A capsular polysaccharide.
    Gao Q; Zaccaria C; Tontini M; Poletti L; Costantino P; Lay L
    Org Biomol Chem; 2012 Sep; 10(33):6673-81. PubMed ID: 22850927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological evaluation of phosphono analogues of capsular polysaccharide fragments from Neisseria meningitidis A.
    Torres-Sanchez MI; Zaccaria C; Buzzi B; Miglio G; Lombardi G; Polito L; Russo G; Lay L
    Chemistry; 2007; 13(23):6623-35. PubMed ID: 17508372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoactivity of protein conjugates of carba analogues from Neisseria meningitidis a capsular polysaccharide.
    Gao Q; Tontini M; Brogioni G; Nilo A; Filippini S; Harfouche C; Polito L; Romano MR; Costantino P; Berti F; Adamo R; Lay L
    ACS Chem Biol; 2013 Nov; 8(11):2561-7. PubMed ID: 24000773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modeling of synthetic phosphono and carba analogues of N-acetyl-alpha-D-mannosamine 1-phosphate, the repeating unit of the capsular polysaccharide from Neisseria meningitidis serovar A.
    Toma L; Legnani L; Rencurosi A; Poletti L; Lay L; Russo G
    Org Biomol Chem; 2009 Sep; 7(18):3734-40. PubMed ID: 19707677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the conformations of Neisseria meningitidis serogroup a CPS and a carba-analogue: Implications for vaccine development.
    Hlozek J; Ravenscroft N; Kuttel MM
    Carbohydr Res; 2019 Dec; 486():107838. PubMed ID: 31654945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Towards a synthetic glycoconjugate vaccine against Neisseria meningitidis A.
    Berkin A; Coxon B; Pozsgay V
    Chemistry; 2002 Oct; 8(19):4424-33. PubMed ID: 12355530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
    Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
    Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A stabilized glycomimetic conjugate vaccine inducing protective antibodies against Neisseria meningitidis serogroup A.
    Enotarpi J; Tontini M; Balocchi C; van der Es D; Auberger L; Balducci E; Carboni F; Proietti D; Casini D; Filippov DV; Overkleeft HS; van der Marel GA; Colombo C; Romano MR; Berti F; Costantino P; Codeé JDC; Lay L; Adamo R
    Nat Commun; 2020 Sep; 11(1):4434. PubMed ID: 32895393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative stability of meningococcal serogroup A and X polysaccharides.
    Berti F; Romano MR; Micoli F; Pinto V; Cappelletti E; Gavini M; Proietti D; Pluschke G; MacLennan CA; Costantino P
    Vaccine; 2012 Oct; 30(45):6409-15. PubMed ID: 22921741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution.
    Marc LaForce F; Ravenscroft N; Djingarey M; Viviani S
    Vaccine; 2009 Jun; 27 Suppl 2():B13-9. PubMed ID: 19477559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Conformation of the Mannopyranosyl Phosphate Repeating Unit of the Capsular Polysaccharide of
    Calloni I; Unione L; Jiménez-Osés G; Corzana F; Del Bino L; Corrado A; Pitirollo O; Colombo C; Lay L; Adamo R; Jiménez-Barbero J
    European J Org Chem; 2018 Sep; 2018(33):4548-4555. PubMed ID: 30443159
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation and characterization of an immunogenic meningococcal group A conjugate vaccine for use in Africa.
    Lee CH; Kuo WC; Beri S; Kapre S; Joshi JS; Bouveret N; LaForce FM; Frasch CE
    Vaccine; 2009 Jan; 27(5):726-32. PubMed ID: 19063929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformations of Neisseria meningitidis serogroup A and X polysaccharides: The effects of chain length and O-acetylation.
    Hlozek J; Kuttel MM; Ravenscroft N
    Carbohydr Res; 2018 Jul; 465():44-51. PubMed ID: 29940397
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of structures corresponding to the capsular polysaccharide of Neisseria meningitidis group A.
    Slättegård R; Teodorovic P; Kinfe HH; Ravenscroft N; Gammon DW; Oscarson S
    Org Biomol Chem; 2005 Oct; 3(20):3782-7. PubMed ID: 16211114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient solid-phase synthesis of meningococcal capsular oligosaccharides enables simple and fast chemoenzymatic vaccine production.
    Fiebig T; Litschko C; Freiberger F; Bethe A; Berger M; Gerardy-Schahn R
    J Biol Chem; 2018 Jan; 293(3):953-962. PubMed ID: 29187601
    [No Abstract]   [Full Text] [Related]  

  • 16. Neisseria meningitidis serogroup A vaccines: an overview.
    Vergnano S; Heath P
    Expert Rev Vaccines; 2003 Aug; 2(4):571-82. PubMed ID: 14711341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunogenicity and bactericidal activity in mice of an outer membrane protein vesicle vaccine against Neisseria meningitidis serogroup A disease.
    Norheim G; Arne Høiby E; Caugant DA; Namork E; Tangen T; Fritzsønn E; Rosenqvist E
    Vaccine; 2004 Jun; 22(17-18):2171-80. PubMed ID: 15149774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neisseria meningitidis serogroups A and W-135: carriage and immunity in Burkina Faso, 2003.
    Mueller JE; Yaro S; Traore Y; Sangare L; Tarnagda Z; Njanpop-Lafourcade BM; Borrow R; Gessner BD
    J Infect Dis; 2006 Mar; 193(6):812-20. PubMed ID: 16479516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An outer membrane vesicle vaccine for prevention of serogroup A and W-135 meningococcal disease in the African meningitis belt.
    Norheim G; Tunheim G; Næss LM; Kristiansen PA; Caugant DA; Rosenqvist E
    Scand J Immunol; 2012 Aug; 76(2):99-107. PubMed ID: 22537024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.
    Okoko BJ; Idoko OT; Adegbola RA
    Vaccine; 2009 Mar; 27(14):2023-9. PubMed ID: 19095025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.